CHANGE IN RATINGS
Omega Healthcare Investors
upgraded at UBS to Neutral from Sell. Cites better risk/reward, given recent sell-off. Lowered target price to $15.50 from $16.50.
upgraded at Bear Stearns to Peer Perform from Underperform based on valuation. Cites shares are now trading within 7% of year-end 2008 target price of $166.